Byrne Financial Freedom’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$527K Buy
1,454
+67
+5% +$22.9K 0.21% 66
2026
Q1
$488K Sell
1,387
-132
-9% -$47.1K 0.23% 57
2025
Q4
$497K Buy
1,519
+245
+19% +$77.7K 0.23% 58
2025
Q3
$359K Buy
+1,274
New +$369K 0.18% 70

Other funds holding AMGN

Byrne Financial Freedom's AMGN Position: Q2 2026 in Review

Byrne Financial Freedom increased its Amgen (AMGN) stake by 4.8% in Q2 2026, buying an estimated $22.9K and bringing the position to 1,454 shares worth $527K. The position accounts for 0.21% of the portfolio, ranked #66.

Byrne Financial Freedom first reported a position in AMGN in Q3 2025 and has held it in 4 quarters since. 3,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Byrne Financial Freedom held 1,454 shares of Amgen worth $527K as of Q2 2026.
  • Byrne Financial Freedom bought 67 Amgen shares in Q2 2026, an estimated $22.9K.
  • Amgen made up 0.21% of Byrne Financial Freedom's portfolio in Q2 2026, its #66 holding.
  • Byrne Financial Freedom first reported a position in Amgen in Q3 2025 and has held it in 4 quarters since.
  • 3,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Byrne Financial Freedom's 13F filing for Q2 2026, filed 30 Jul 2026.